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Atrial fibrillation (AF), the commonest dysrhythmia, affects nearly 4.5 million people in 
Europe and 2.2 million in the US. Prevalence increases with age (4% over 60 years and 9% 
over 80) and impact on quality of life and health resources is considerable. Fibrillating atria 
have no contractile function. The most serious complication is thromboembolic stroke (12500 
strokes attributed to AF annually in the UK). To reduce thromboembolism, patients are 
anticoagulated, increasing bleeding risk. AF also exacerbates heart failure and is a rising 
public health burden as the population ages. 
The maze procedure creates lesions in the atria to obstruct the macro-re-entry circuits 
essential to sustain AF. Maze is most commonly performed as an adjunct to major cardiac 
surgery and significantly increases 12-month freedom from AF, restoring sinus rhythm (SR) 
in 44% - 94% of treated patients compared to 5% - 33% of controls (1). Restoring SR does 
not guarantee return of atrial contractile function, and both thromboembolism and heart 
failure exacerbation are related to the loss of contractile function (2).  
Studies of atrial transport after maze are limited by small samples, selection bias and lack of 
matched controls. The HESTER (Has Electrical Sinus Translated into Effective 
Remodelling?) matched cohort study, compared atrial transport in patients whose SR was 
restored by maze with those in SR before and after cardiac surgery. The maze cohort were in 
SR at least one year after receiving maze for persistent longstanding AF as an adjunct to 
cardiac surgery. The control cohort were patients in SR both before and at least one year after 
cardiac surgery, matched one-to-one for time since procedure (± 6 months), age (± 5 years), 
sex, type of surgery, left ventricular function, and risk profile (logistic EuroSCORE). The aim 
was to assess whether the two cohorts had equivalent LA function, primarily active LA 
ejection fraction (ALAEF).  ܣܮܣܧܨ ൌ ͳͲͲ ൈ ܮܣ ௣ܸ௥௘஺ െ ܮܣ ௠ܸ௜௡ܮܣ ௣ܸ௥௘஺ Ǥ 
Secondary outcomes were LA volume measurements, active and passive stroke volume and 
LA ejection fraction. 
4 
 
LA function evaluation was by transthoracic echocardiography and multislice MRI. For each 
modality, a single operator blinded to the cohort performed the test and interpreted the 
findings. A mixed effects linear regression model was fitted, including treatment and 
matching variables (fixed effects) and matched pairs (random effects). An unconstrained 
covariance model was assumed, with residuals at both levels presumed independent and 
normally distributed. The estimated treatment coefficient was taken as the mean ALAEF 
difference. In normal subjects in SR, the standard deviation in ALAEF was 18.2% (3). This 
was taken as the minimum clinically important ALAEF difference.  
Between 2013 to 2015, 22 patients were recruited per cohort and had LA functional 
measurements. Maze patients had lower mean ALAEF (18.4%) than controls (26%). One-to-
one comparison shows that controls had higher ALAEF in all but three pairs (Figure 1A). 
After adjusting for the paired design and matching variables, mean ALAEF was 8.03% lower 
in maze than controls (95% CI -12.43%, -3.62%, p=0.0015), but the confidence interval was 
entirely contained within the standard deviation of normal subjects (±18.2%). This study 
demonstrates no clinically important difference in ALAEF between patients in SR after maze 
procedure and matched controls who were in SR before and after cardiac surgery but average 
ALAEF was lower in maze than controls.  Results of regression analyses for secondary 
outcomes are shown in Figure 1B. 
Patients with chronic AF may have persistent LA dysfunction, even after restoration of SR by 
ablation. Buber et al reported that absence of LA contraction, despite SR restoration, is 
associated with a significant increase in the risk of thromboembolic stroke after maze. Global 
and regional atrial dysfunction may be the result of a combination of injury from the ablation 
process and pre-existing disease (2). The two adverse features of asymptomatic AF, 
thromboembolism and impact on cardiac function, are both directly related to atrial function. 
Restoring SR without restoring function is unlikely to be of clinical benefit. HESTER 
provides evidence that function is indeed restored after adjunct maze with potential clinical 
benefits in reducing thromboembolic and heart failure risk. Whether patients can safely stop 
taking anticoagulants after SR is restored by a maze procedure requires long-term follow-up 
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and stroke surveillance, and HESTER does not answer this question. The varying rates of LA 
functional recovery after maze mean that it would be prudent to measure atrial function 
before considering anticoagulation withdrawal.  
In summary, return to SR after adjunct maze is associated with recovery of LA function, with 
an ALAEF smaller than controls but within the predetermined clinically acceptable range of 
variation. This functional recovery and the variability observed have important implications 
for survival, heart function and clinical decisions on long-term anticoagulation.  
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Figure 1 
 
A. 
ALAEF measurements for individual patients undergoing the maze procedure and their 
matched controls 
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B.  
Forest plots showing estimated treatment effects (maze-control) and 95% confidence intervals 
for secondary outcomes 
 
 
 
 
 
